| Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ... The Lancet Neurology 16 (10), 797-812, 2017 | 499 | 2017 |
| Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, B Wegner, ... Annals of neurology 79 (2), 206-216, 2016 | 395 | 2016 |
| The APOSTEL recommendations for reporting quantitative optical coherence tomography studies A Cruz-Herranz, LJ Balk, T Oberwahrenbrock, S Saidha, ... Neurology 86 (24), 2303-2309, 2016 | 387 | 2016 |
| Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study EH Martinez-Lapiscina, S Arnow, JA Wilson, S Saidha, JL Preiningerova, ... The Lancet Neurology 15 (6), 574-584, 2016 | 363 | 2016 |
| Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria S Schippling, LJ Balk, F Costello, P Albrecht, L Balcer, PA Calabresi, ... Multiple sclerosis journal 21 (2), 163-170, 2015 | 281 | 2015 |
| Effects of dimethyl fumarate on neuroprotection and immunomodulation P Albrecht, I Bouchachia, N Goebels, N Henke, HH Hofstetter, A Issberner, ... Journal of neuroinflammation 9, 1-10, 2012 | 252 | 2012 |
| Optical coherence tomography in parkinsonian syndromes P Albrecht, AK Müller, M Südmeyer, S Ferrea, M Ringelstein, E Cohn, ... PloS one 7 (4), e34891, 2012 | 217 | 2012 |
| Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc as a neuroprotective drug target P Albrecht, J Lewerenz, S Dittmer, R Noack, P Maher, A Methner CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2010 | 209 | 2010 |
| Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, K Hellwig, ... Neurology: Neuroimmunology & Neuroinflammation 5 (6), e504, 2018 | 203 | 2018 |
| Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro J Lewerenz, P Albrecht, MLT Tien, N Henke, S Karumbayaram, ... Journal of neurochemistry 111 (2), 332-343, 2009 | 200 | 2009 |
| Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis ME Ward, R Chen, HY Huang, C Ludwig, M Telpoukhovskaia, A Taubes, ... Science translational medicine 9 (385), eaah5642, 2017 | 178 | 2017 |
| Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography P Albrecht, M Ringelstein, AK Müller, N Keser, T Dietlein, A Lappas, ... Multiple Sclerosis Journal 18 (10), 1422-1429, 2012 | 149 | 2012 |
| Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study LJ Balk, A Cruz-Herranz, P Albrecht, S Arnow, JM Gelfand, P Tewarie, ... Journal of neurology 263, 1323-1331, 2016 | 144 | 2016 |
| High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy P Albrecht, A Jansen, JI Lee, M Moll, M Ringelstein, D Rosenthal, ... Neurology 92 (1), e48-e54, 2019 | 132 | 2019 |
| APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies A Aytulun, A Cruz-Herranz, O Aktas, LJ Balcer, L Balk, P Barboni, ... Neurology 97 (2), 68-79, 2021 | 125 | 2021 |
| Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity M Liebmann, S Hucke, K Koch, M Eschborn, J Ghelman, AI Chasan, ... Proceedings of the National Academy of Sciences 115 (34), E8017-E8026, 2018 | 116 | 2018 |
| Charcot–Marie–Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential R Noack, S Frede, P Albrecht, N Henke, A Pfeiffer, K Knoll, T Dehmel, ... Human molecular genetics 21 (1), 150-162, 2012 | 106 | 2012 |
| The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress N Henke, P Albrecht, I Bouchachia, M Ryazantseva, K Knoll, J Lewerenz, ... Cell death & disease 4 (1), e470-e470, 2013 | 101 | 2013 |
| Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis P Albrecht, R Fröhlich, HP Hartung, BC Kieseier, A Methner Journal of neurology 254 (11), 1595-1596, 2007 | 101 | 2007 |
| Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study FC Oertel, J Havla, A Roca-Fernández, N Lizak, H Zimmermann, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (12), 1259-1265, 2018 | 100 | 2018 |
Axel MethnerProfessor of Neurology, University Medical Center Mainz在 unimedizin-mainz.de 的电子邮件经过验证
